5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 191.31▲ | 189.52▲ |
MA10 | N/A | N/A | N/A | 189.71▲ | 187.09▲ |
MA20 | N/A | N/A | N/A | 188.33▲ | 191.63▲ |
MA50 | N/A | N/A | N/A | 187.53▲ | 188.89▲ |
MA100 | N/A | N/A | N/A | 192.83▲ | 174.69▲ |
MA200 | N/A | N/A | N/A | 188.09▲ | 159.08▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.736▲ | 0.224▲ |
RSI | N/A | N/A | N/A | 66.017▲ | 55.354▲ |
STOCH | N/A | N/A | N/A | 92.416▲ | 69.869 |
WILL %R | N/A | N/A | N/A | 0.000▲ | -31.359 |
CCI | N/A | N/A | N/A | 191.802▲ | 146.561▲ |
Friday, November 22, 2024 12:23 PM
Fintel reports that on November 22, 2024, Leerink Partners upgraded their outlook for AbbVie (LSE:0QCV) from Market Perform to Outperform. As of November 21, 2024, the average one-year price ...
|
Tuesday, October 22, 2024 05:00 PM
Fintel reports that on November 4, 2024, Argus Research upgraded their outlook for AbbVie (LSE:0QCV) from Hold to Buy. As of October 23, 2024, the average one-year price target for AbbVie is 205. ...
|
Tuesday, October 22, 2024 05:00 PM
Fintel reports that on November 4, 2024, Argus Research upgraded their outlook for AbbVie (LSE:0QCV) from Hold to Buy. As of October 23, 2024, the average one-year price target for AbbVie is 205. ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
10/07/25 | 189.60 | 196.40 | 189.51 | 196.40 | 32 |
09/07/25 | 190.50 | 190.50 | 188.40 | 190.50 | 86 |
08/07/25 | 188.99 | 189.80 | 188.99 | 189.80 | 13 |
07/07/25 | 188.99 | 191.05 | 188.99 | 191.05 | 36 |
04/07/25 | 188.80 | 188.99 | 188.80 | 188.80 | 53 |
03/07/25 | 189.80 | 189.80 | 188.99 | 189.80 | 53 |
02/07/25 | 187.10 | 189.60 | 186.08 | 189.60 | 61 |
01/07/25 | 186.08 | 189.60 | 186.08 | 189.60 | 34 |
30/06/25 | 185.00 | 186.08 | 185.00 | 185.00 | 34 |
27/06/25 | 186.30 | 186.50 | 186.08 | 186.50 | 65 |
|
|
||||
|
|
||||
|
|